GlassScriptPhysician profile
Spiro Constantine Karras
NPI 1295836484
$1,644.23
in general payments reported to CMS, 2019-2025
7 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $74.11 · 2021: $440 · 2022: $79.42 · 2023: $311 · 2024: $167 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503 · Gift: $76.25 · Entertainment: $31.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.49 |
| Gift | $76.25 |
| Entertainment | $31.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $729.87 | 2019-2025 | |
| Biohorizons Implant Systems INC. | $471.08 | 2020-2025 | Biohorizons, Biohorizons Dental Implants |
| Nobel Biocare USA | $139.19 | 2019-2022 | |
| Southern Implants North America INC | $127.35 | 2019 | |
| Revance Therapeutics, INC. | $70.78 | 2024 | Daxxify |
| Ormco Corporation | $69.34 | 2021 | |
| Southern Anesthesia & Surgical, INC (Dba Ace Southern) | $36.62 | 2023 | Nuoss |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spiro Karras listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.